BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 10415444)

  • 21. Environmental and chemical carcinogenesis.
    Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
    Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of xenobiotic-metabolizing enzymes by ethanolic neem leaf extract during hamster buccal pouch carcinogenesis.
    Subapriya R; Velmurugan B; Nagini S
    J Exp Clin Cancer Res; 2005 Jun; 24(2):223-30. PubMed ID: 16110755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of non-nutrient plant components on biotransformation enzymes.
    Van Bladeren PJ
    Biomed Pharmacother; 1997; 51(8):324-7. PubMed ID: 9436524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of heat-treated proteins on selected parameters of the biotransformation system in the rat.
    Wenzel E; Tasto S; Erbersdobler HF; Faist V
    Ann Nutr Metab; 2002; 46(1):9-16. PubMed ID: 11914510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of neoplasia by minor dietary constituents.
    Wattenberg LW
    Cancer Res; 1983 May; 43(5 Suppl):2448s-2453s. PubMed ID: 6403236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human cytochrome p450 enzymes of importance for the bioactivation of methyleugenol to the proximate carcinogen 1'-hydroxymethyleugenol.
    Jeurissen SM; Bogaards JJ; Boersma MG; ter Horst JP; Awad HM; Fiamegos YC; van Beek TA; Alink GM; Sudhölter EJ; Cnubben NH; Rietjens IM
    Chem Res Toxicol; 2006 Jan; 19(1):111-6. PubMed ID: 16411663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Biotransformation in occupational medicine: the role of hepatic cytochrome P-450 in the mechanism of action and the biological monitoring of occupational toxic compounds].
    Manno M; Saia B
    Med Lav; 1994; 85(1):11-21. PubMed ID: 8035741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting carcinogen metabolism by dietary cancer preventive compounds.
    Yu S; Kong AN
    Curr Cancer Drug Targets; 2007 Aug; 7(5):416-24. PubMed ID: 17691900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prevention of renal carcinoma: the nutri-genetic approach].
    Junien C; Dupret JM; Gallou C; Longuemaux S; Richard S; Saquet C; Krishnamoorty R; Delomenie C; Droz D; Bouvier R; Chauveau D; Joly D; Grunfeld JP; Chretien Y; Mejean A; Beroud C
    J Soc Biol; 2000; 194(1):29-38. PubMed ID: 11107547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation or detoxification of mutagenic and carcinogenic compounds in transgenic Drosophila expressing human glutathione S-transferase.
    Chroust K; Jowett T; Farid-Wajidi MF; Huang JY; Ryskova M; Wolf R; Holoubek I
    Mutat Res; 2001 Nov; 498(1-2):169-79. PubMed ID: 11673082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone bioactivation in mouse by dietary phenethyl isothiocyanate.
    Smith TJ; Guo Z; Li C; Ning SM; Thomas PE; Yang CS
    Cancer Res; 1993 Jul; 53(14):3276-82. PubMed ID: 8324738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protection against 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine cytotoxicity and DNA adduct formation in human prostate by glutathione S-transferase P1.
    Nelson CP; Kidd LC; Sauvageot J; Isaacs WB; De Marzo AM; Groopman JD; Nelson WG; Kensler TW
    Cancer Res; 2001 Jan; 61(1):103-9. PubMed ID: 11196146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glutathione conjugation as a bioactivation reaction.
    van Bladeren PJ
    Chem Biol Interact; 2000 Dec; 129(1-2):61-76. PubMed ID: 11154735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [GSH and GSH S-transferase involvement in the bioactivation of xenobiotics. Carcinogen conjugation with reactive metabolites].
    Jerca L; Filip F; Alexa ID; Jerca O
    Rev Med Chir Soc Med Nat Iasi; 1995; 99(3-4):23-8. PubMed ID: 9455345
    [No Abstract]   [Full Text] [Related]  

  • 35. Biotransformation of aflatoxin B1 in human lung.
    Donnelly PJ; Stewart RK; Ali SL; Conlan AA; Reid KR; Petsikas D; Massey TE
    Carcinogenesis; 1996 Nov; 17(11):2487-94. PubMed ID: 8968067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of procarcinogens by human cytochrome P450 enzymes.
    Guengerich FP; Shimada T
    Mutat Res; 1998 May; 400(1-2):201-13. PubMed ID: 9685642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of aflatoxin carcinogenesis.
    Eaton DL; Gallagher EP
    Annu Rev Pharmacol Toxicol; 1994; 34():135-72. PubMed ID: 8042848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytochrome P-450 enzymes as targets for chemoprevention against chemical carcinogenesis and toxicity: opportunities and limitations.
    Yang CS; Smith TJ; Hong JY
    Cancer Res; 1994 Apr; 54(7 Suppl):1982s-1986s. PubMed ID: 8137324
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of basal level metabolic enzyme activities of freshly isolated hepatocytes from rainbow trout (Oncorhynchus mykiss) and rat.
    Nabb DL; Mingoia RT; Yang CH; Han X
    Aquat Toxicol; 2006 Oct; 80(1):52-9. PubMed ID: 16935359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dietary modulation of the biotransformation and genotoxicity of aflatoxin B(1).
    Gross-Steinmeyer K; Eaton DL
    Toxicology; 2012 Sep; 299(2-3):69-79. PubMed ID: 22640941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.